Sign In
Buy DCGO
$0.651
-0.0163 (-2.44%)
At Close: Jul 31, 2026
Last-mile health services company DocGo stock surges on 2023 revenue guidance
04:47pm, Monday, 13'th Mar 2023
DocGo Inc posted full-year 2022 and fourth quarter results after the bell Monday, but its 2023 guidance is what caught investors' attention. DocGo projects 2023 revenue between $500 million to $510 m
Preview: DocGo expected to extend its track record of beating estimates, analysts say
01:24pm, Thursday, 09'th Mar 2023
DocGo Inc is expected to extend its track record of beating consensus estimates when it reports its fourth-quarter earnings on March 13, according to Canaccord Genuity (TSX:CF, LSE:CF) analysts. In a
DocGo to Announce Fourth Quarter and Full-Year 2022 Results on Monday, March 13
07:35am, Tuesday, 21'st Feb 2023
NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the fourth quarter and full-year ended
DocGo: Can Sustain Rapid, Profitable Expansion
06:39am, Wednesday, 11'th Jan 2023
COVID has pulled forward consumer adoption of telehealth. DocGo offers a fully integrated platform.
DocGo Announces Upcoming Participation in Two Investor Conferences
07:35am, Tuesday, 03'rd Jan 2023
NEW YORK--( BUSINESS WIRE )--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will present at the 41st Ann
MDA Breakout Stocks Week 1 - January 2023: High-Frequency Gainers To Give You An Edge
10:12am, Monday, 02'nd Jan 2023
Two new Breakout Stocks for Week 1 with better than 10% short-term upside potential and two Dow 30 Picks. Average cumulative returns for 2022 reached +142.69% YTD. The streak of weekly picks gaining o
DocGo to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
07:35am, Tuesday, 22'nd Nov 2022
NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President, will participate in Benchmark Company's 11th
DocGo: Current Post-Earnings Sell-Off Presents Double-Digit Upside Potential
02:54pm, Monday, 21'st Nov 2022
DocGo Q3 beat topline revenue but missed bottom-line earnings; however, that was due to accounting for a one-time loss from the remeasurement of warrant liabilities. The end of Covid Testing did not m
DocGo Announces Upcoming Participation in Four Investor Conferences
09:15am, Wednesday, 09'th Nov 2022
NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President will participate at the following four investor
DocGo Inc. (DCGO) Q3 2022 Earnings Call Transcript
09:14pm, Monday, 07'th Nov 2022
DocGo Inc. (NASDAQ:DCGO ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Mike Cole - Vice President, IR Stan Vashovsky - CEO, Co-Founder Andre Oberholzer - CFO Antho
DocGo to Announce Third Quarter 2022 Results on Monday, November 7
04:35pm, Wednesday, 26'th Oct 2022
NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO) will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7.
DocGo Announces Upcoming Participation at LD Micro Investor Conference
07:35am, Thursday, 20'th Oct 2022
NEW YORK--(BUSINESS WIRE)--DocGo's Vice President of Investor Relations, Michael Cole, to participate at LD Micro's The Main Event investor conference 10/25 at 11:00 AM ET.
Is Motion Acquisition (DCGO) Outperforming Other Medical Stocks This Year?
11:17am, Tuesday, 27'th Sep 2022
Here is how DocGo Inc. (DCGO) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.
3 IPO Stocks That You Want to Own
09:23am, Sunday, 25'th Sep 2022
This down market is giving us some really intriguing stocks at cheap prices.
This Company Could Beat Out Teladoc, and It's Not Amazon
09:40am, Thursday, 22'nd Sep 2022
A potentially disruptive business model is finding its legs in the post-pandemic healthcare landscape.
